A recent Taiwan survey revealed that COPD cardiovascular risk affects 61 percent of patients with chronic obstructive pulmonary disease, the Taiwan Society of Pulmonary and Critical Care Medicine said. The findings highlight the overlap between COPD and cardiovascular disease and signal urgent public health concerns.
Group president Chen Yu-min explained that COPD ranks as the fourth-leading cause of death globally. In Taiwan, more than 6,000 people die from COPD each year. Experts cited a 67-year-old man who lost consciousness due to chest tightness and was diagnosed with heart failure, showing the real-world consequences of COPD cardiovascular risk.
Physician Su Kang-cheng said that acute COPD episodes raise the chance of cardiovascular events by 4.6 times. Even six months to a year after an exacerbation, patients still face elevated heart risk. The survey included 1,240 patients and followed the latest Global Initiative for Chronic Obstructive Lung Disease guidelines, adding cardiovascular comorbidities.
Experts urged preventive measures. Quitting smoking lowers COPD exacerbation risk by 31 percent and cardiovascular event risk by 25 percent. Vaccinations against respiratory infections and pulmonary rehabilitation reduce COPD exacerbation risks by 12 and 17 percent, respectively.
Health authorities announced stronger support for patients. National Health Insurance Administration Director-General Chen Lian-yu said the Pay-for-Performance program, active since 2017, will update quality standards from January 1. An extra NT$25 million (US$805,283) will fund the program, with 70 percent going directly to frontline healthcare providers.
Health Promotion Administration Director-General Shen Ching-fen emphasized that smoking cessation remains the top priority. About 99.5 percent of contracted hospitals and clinics provide smoking cessation services.
The survey and expert recommendations underline that managing COPD cardiovascular risk requires lifestyle changes, medical supervision, and enhanced public health programs to reduce deaths and improve patient outcomes.
